Dual Incretin Agonist 30mg — Verification Report

From Double R Labs · Lot DRL-04-TZ30 · Tested April 2026

← Back to Double R Labs

VialTalk

Verification report

Dual Incretin Agonist 30mg

Double R Labs

Score

107

Grade

A++

Superlative

Lot DRL-04-TZ30

Tested April 2026

Report ID

07d03bce

Test

Method

Result

Status

PurityFull credit

HPLC

99.82%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentFull credit

Gravimetric vs label claim · tested weight disclosed and verified

30 mg labeled · 34.58 mg tested

Full credit

EndotoxinFull credit

USP <85> compendial

Screened

Full credit

Heavy metalsFull credit

ICP-MS

Screened

Full credit

SterilityPartial

PCR / DNA microarray

Screened

Partial

Batch conformityStrong

Three-to-four vial average

Assessed

Strong

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →